Wockhardt Limited
WOCKPHARMA
Rank in Stocks
#4513
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Share Price
$21.04
Last synced: 2026-10-19
Market Cap
$3.42B
Change (1 day)
-2.39%
Change (1 year)
38.07%
Country
IN
Trade Wockhardt Limited (WOCKPHARMA)
Category
Healthcare
Number of shares outstanding for Wockhardt Limited (WOCKPHARMA)
Number of shares outstanding as of June 2026: 162.49M
According to Wockhardt Limited latest financial reports and stock price the company's current number of shares outstanding is 162.49M. At the end of March 2024 the company had 144.25M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Wockhardt Limited (WOCKPHARMA) from 2004 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 162.49M | 4.41% |
| 2025 | 155.63M | 7.89% |
| 2024 | 144.25M | 0.13% |
| 2023 | 144.06M | 19.50% |
| 2022 | 120.55M | 0.31% |
| 2021 | 120.19M | 0.03% |
| 2020 | 120.15M | 0.05% |
| 2019 | 120.09M | 8.60% |
| 2018 | 110.58M | 0.06% |
| 2017 | 110.51M | -0.60% |
| 2016 | 111.18M | -0.08% |
| 2015 | 111.27M | 0.20% |
| 2014 | 111.04M | -0.15% |
| 2013 | 111.21M | -6.35% |
| 2012 | 118.76M | 0.00% |
| 2011 | 118.76M | 0.00% |
| 2010 | 118.76M | 0.00% |
| 2008 | 118.76M | 0.00% |
| 2007 | 118.76M | 0.02% |
| 2006 | 118.74M | 0.24% |
| 2005 | 118.46M | 0.00% |
| 2004 | 118.46M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 445.06M | 173.90% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 105.38M | -35.15% |
US
|
